Israeli biotech goes to USA for $480 million

Miami-based Opko Health has just taken over Israel’s Prolor Biotech. Prolor develops long-lasting medicines including a human growth hormone, a clotting factor for hemophilia and treatments for diabetes and obesity. The CEO of Opko is also the Chairman of Israel’s Teva.

This entry was posted in Economy & Business. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *